rabeprazole has been researched along with Coronary Artery Disease in 3 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to estimate the effects of gastric acid output suppression with rabeprazole on course of angina pectoris and results of the treadmill stress test in patients with CAD." | 5.11 | Suppression of gastric acid production may improve the course of angina pectoris and the results of treadmill stress test in patients with coronary artery disease. ( Budzyński, J; Fabisiak, J; Kłopocka, M; Majer, M; Morawski, W; Pulkowski, G; Suppan, K; Swiatkowski, M, 2004) |
| "Omeprazole, a PPI, has been reported to weaken the antiplatelet effects of clopidogrel." | 1.38 | Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy. ( Horiuchi, H; Ikeda, T; Imai, M; Jinnai, T; Kato, Y; Kimura, T; Makiyama, T; Shirakawa, R; Tada, T; Tazaki, J; Yamane, K, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siriswangvat, S | 1 |
| Sansanayudh, N | 1 |
| Nathisuwan, S | 1 |
| Panomvana, D | 1 |
| Yamane, K | 1 |
| Kato, Y | 1 |
| Tazaki, J | 1 |
| Tada, T | 1 |
| Makiyama, T | 1 |
| Imai, M | 1 |
| Jinnai, T | 1 |
| Ikeda, T | 1 |
| Shirakawa, R | 1 |
| Kimura, T | 1 |
| Horiuchi, H | 1 |
| Swiatkowski, M | 1 |
| Budzyński, J | 1 |
| Kłopocka, M | 1 |
| Pulkowski, G | 1 |
| Suppan, K | 1 |
| Fabisiak, J | 1 |
| Morawski, W | 1 |
| Majer, M | 1 |
2 trials available for rabeprazole and Coronary Artery Disease
| Article | Year |
|---|---|
Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Diphosphate; Aged; Aspirin; Clopidogrel; Coronary | 2010 |
Suppression of gastric acid production may improve the course of angina pectoris and the results of treadmill stress test in patients with coronary artery disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Angina Pectoris; Anti-Ulcer Agents; Benzimidazoles; Comorbi | 2004 |
1 other study available for rabeprazole and Coronary Artery Disease
| Article | Year |
|---|---|
Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Asian People; Aspirin; Case-Control Studies; Clopidog | 2012 |